Asset Details
Do you wish to reserve the book?
Minimally invasive local therapies for liver cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Minimally invasive local therapies for liver cancer
Do you wish to request the book?
Minimally invasive local therapies for liver cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Minimally invasive local therapies for liver cancer
2014
Overview
Primary and metastatic liver tumors are an increasing global health problem, with hepatocellular carcinoma （HCC） now being the third leading cause of cancer-related mortality worldwide. Systemic treatment options for HCC remain limited, with Sorafenib as the only prospectively validated agent shown to increase overall survival. Surgical resection and/or transplantation, locally ablative therapies and regional or locoregional therapies have filled the gap in liver tumor treatments, providing improved survival outcomes for both primary and metastatic tumors. Minimally invasive local therapies have an increasing role in the treatment of both primary and metastatic liver tumors. For patients with low volume disease, these therapies have now been established into consensus practice guidelines. This review highlights technical aspects and outcomes of commonly utilized, minimally invasive local therapies including laparoscopic liver resection （LLR）, radiofrequency ablation （RFA）, microwave ablation （MWA）, high-intensity focused ultrasound （HIFU）, irreversible electroporation （IRE）, and stereotactic body radiation therapy （SBRT）. In addition, the role of combination treatment strategies utilizing these minimally invasive techniques is reviewed.
Publisher
Chinese Anti-Cancer Association (CACA), Cancer Biology & Medicine,Department of Radiology, Division of Interventional Radiology, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY 10065, USA%Department of Medicine, NYU Langone Medical Center, New York, NY 10016, USA%Department of Surgery, Division of Surgical 0ncology, New York-Presbyterian Hospital/Weill Cornell Medical Center New York, New York, NY 10065, USA%Flushing Radiation 0ncology Services, Flushing, New York, NY 11354, USA,Chinese Anti-Cancer Association,China Anti-Cancer Association
